Abbott Laboratories (ABT) stock is in focus as a Chicago jury boosts the damages the company has to pay in a baby formula ...
The latest health news covers AG1's exploration of a sale, a genetic link to GLP-1 drug efficacy, Amgen's lung cancer therapy approval in China, FDA's rejection of Replimune's skin cancer drug, and a ...
Free Malaysia Today on MSN
Jury orders Abbott to pay US$70mil in preterm infant formula trial
The trial was the latest among hundreds of lawsuits alleging that Abbott's cow's milk-based formula products for preterm ...
A Cook County jury found the Lake County company's cow-milk-based infant formula contributed to a life-threatening condition ...
Health sector updates include AG1 exploring business sale options, genetic links to effective GLP-1 obesity drugs, Amgen's lung cancer drug approval in China, Kennedy's vaccine advisory panel focusing ...
A Cook County jury has returned a verdict of $70 million including $17 million in punitive damages against Abbott Laboratories, the manufacturer of the cow's milk-based infant feeding product Similac.
A Cook County jury on Friday decided that Abbott Laboratories should pay $17 million in punitive damages – on top of the $53 ...
WALB on MSN
‘She only lived eight days, but she changed our lives forever’: Mother turns loss into hope
Every month on Harper’s birthday, the foundation donates a basket of items for mothers and babies to a NICU family at Phoebe.
"I have learned to carry the unfathomable loss of Micah and channel all that love and energy into fueling the NEC Society’s ...
Pune: A 26-week premature baby weighing just 540gm at birth was successfully treated and discharged after 68 days in the ...
A Chicago jury has ordered Abbott Laboratories to pay $53M in compensatory damages to a group of families that had accused the company that its premature infant formula caused a serious bowel disease.
A Cook County judge read the jurors' verdict Friday: in all, $17 million in punitive damages to the mothers of babies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results